Exicon Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Exicon şirketinin toplam hissedar öz sermayesi ₩148.4B ve toplam borcu ₩7.7B olup, bu da borç-öz sermaye oranını 5.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₩162.9B ve ₩14.5B dir.

Anahtar bilgiler

5.2%

Borç/özkaynak oranı

₩7.75b

Borç

Faiz karşılama oranın/a
Nakit₩12.83b
Eşitlik₩148.42b
Toplam yükümlülükler₩14.47b
Toplam varlıklar₩162.89b

Son finansal sağlık güncellemeleri

Recent updates

Exicon Co., Ltd. (KOSDAQ:092870) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Sep 06
Exicon Co., Ltd. (KOSDAQ:092870) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Exicon Co., Ltd.'s (KOSDAQ:092870) Shares Climb 28% But Its Business Is Yet to Catch Up

Jul 21
Exicon Co., Ltd.'s (KOSDAQ:092870) Shares Climb 28% But Its Business Is Yet to Catch Up

More Unpleasant Surprises Could Be In Store For Exicon Co., Ltd.'s (KOSDAQ:092870) Shares After Tumbling 25%

Apr 29
More Unpleasant Surprises Could Be In Store For Exicon Co., Ltd.'s (KOSDAQ:092870) Shares After Tumbling 25%

Exicon's (KOSDAQ:092870) Soft Earnings Don't Show The Whole Picture

Mar 25
Exicon's (KOSDAQ:092870) Soft Earnings Don't Show The Whole Picture

Exicon Co., Ltd. (KOSDAQ:092870) Stock Rockets 45% As Investors Are Less Pessimistic Than Expected

Mar 08
Exicon Co., Ltd. (KOSDAQ:092870) Stock Rockets 45% As Investors Are Less Pessimistic Than Expected

Exicon (KOSDAQ:092870) Is Doing The Right Things To Multiply Its Share Price

Mar 07
Exicon (KOSDAQ:092870) Is Doing The Right Things To Multiply Its Share Price

Slowing Rates Of Return At Exicon (KOSDAQ:092870) Leave Little Room For Excitement

May 06
Slowing Rates Of Return At Exicon (KOSDAQ:092870) Leave Little Room For Excitement

When Should You Buy Exicon Co., Ltd. (KOSDAQ:092870)?

Apr 18
When Should You Buy Exicon Co., Ltd. (KOSDAQ:092870)?

Exicon (KOSDAQ:092870) Has A Pretty Healthy Balance Sheet

Mar 16
Exicon (KOSDAQ:092870) Has A Pretty Healthy Balance Sheet

The Exicon (KOSDAQ:092870) Share Price Is Up 101% And Shareholders Are Boasting About It

Mar 01
The Exicon (KOSDAQ:092870) Share Price Is Up 101% And Shareholders Are Boasting About It

Do Institutions Own Exicon Co., Ltd. (KOSDAQ:092870) Shares?

Feb 14
Do Institutions Own Exicon Co., Ltd. (KOSDAQ:092870) Shares?

Is Exicon Co., Ltd. (KOSDAQ:092870) A Smart Choice For Dividend Investors?

Feb 01
Is Exicon Co., Ltd. (KOSDAQ:092870) A Smart Choice For Dividend Investors?

The Returns At Exicon (KOSDAQ:092870) Provide Us With Signs Of What's To Come

Jan 19
The Returns At Exicon (KOSDAQ:092870) Provide Us With Signs Of What's To Come

Is Now The Time To Look At Buying Exicon Co., Ltd. (KOSDAQ:092870)?

Jan 06
Is Now The Time To Look At Buying Exicon Co., Ltd. (KOSDAQ:092870)?

Exicon Co., Ltd. (KOSDAQ:092870) Passed Our Checks, And It's About To Pay A ₩50.00 Dividend

Dec 24
Exicon Co., Ltd. (KOSDAQ:092870) Passed Our Checks, And It's About To Pay A ₩50.00 Dividend

Exicon Co., Ltd.'s (KOSDAQ:092870) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 18
Exicon Co., Ltd.'s (KOSDAQ:092870) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Is Exicon (KOSDAQ:092870) A Risky Investment?

Nov 17
Is Exicon (KOSDAQ:092870) A Risky Investment?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A092870 'nin kısa vadeli varlıkları ( ₩45.3B ) kısa vadeli yükümlülüklerini ( ₩10.8B ) aşıyor.

Uzun Vadeli Yükümlülükler: A092870 şirketinin kısa vadeli varlıkları ( ₩45.3B ) uzun vadeli yükümlülüklerini ( ₩3.6B ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A092870 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: A092870 'nin borç/öz sermaye oranı son 5 yılda 28% seviyesinden 5.2% seviyesine düştü.

Borç Kapsamı: A092870 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: A092870 şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.


Bilanço


Sağlıklı şirketleri keşfedin